VC

Vivo Capital Portfolio holdings

AUM $977M
1-Year Return 209.68%
This Quarter Return
+35.39%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
AUM
$1.39B
AUM Growth
+$291M
Cap. Flow
+$54.5M
Cap. Flow %
3.9%
Top 10 Hldgs %
62%
Holding
63
New
10
Increased
3
Reduced
21
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACRS icon
51
Aclaris Therapeutics
ACRS
$213M
$2.67M 0.19%
1,647,214
MREO
52
Mereo BioPharma
MREO
$290M
$2.38M 0.17%
+778,000
New +$2.38M
DBVT
53
DBV Technologies
DBVT
$272M
$1.19M 0.09%
27,000
DTIL icon
54
Precision BioSciences
DTIL
$58.9M
$1.17M 0.08%
4,675
COLL icon
55
Collegium Pharmaceutical
COLL
$1.19B
-447,173
Closed -$7.3M
QURE icon
56
uniQure
QURE
$929M
-22,932
Closed -$1.09M
SLNO icon
57
Soleno Therapeutics
SLNO
$3.01B
-134,758
Closed -$4.81M
XENE icon
58
Xenon Pharmaceuticals
XENE
$2.87B
-396,589
Closed -$4.5M
KRTX
59
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-223,692
Closed -$16.1M
TRIL
60
DELISTED
Trillium Therapeutics Inc.
TRIL
-2,054,468
Closed -$8.3M
CHMA
61
DELISTED
Chiasma, Inc. Common Stock
CHMA
-1,272,156
Closed -$4.64M
NBRV
62
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-6,817
Closed -$980K
FTSV
63
DELISTED
Forty Seven, Inc. Common Stock
FTSV
-395,691
Closed -$37.8M